Last reviewed · How we verify
NCT06816875
Comparison of the User Experience of Four Nasal Aspirators in Infants
NA trial testing NozeBot Electric Nasal Aspirator in Upper Respiratory Tract Infection in 28 participants. Completed in 17 December 2025.
17 December 2025
Quick facts
| Lead sponsor | Children's Hospital of Eastern Ontario |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 28 |
| Start date | 5 March 2025 |
| Primary completion | 17 December 2025 |
| Estimated completion | 17 December 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- NozeBot Electric Nasal Aspirator
- NoseFrida the SnotSucker
- hydraSense Baby Nasal Care Nasal Aspirator Starter Kit
- Braun Nasal Aspirator
Conditions studied
- Upper Respiratory Tract Infection — all drugs for Upper Respiratory Tract Infection →
Sponsor
Children's Hospital of Eastern Ontario
Who can join
Eligibility, any sex, with Upper Respiratory Tract Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the caregiver's user experience, and overall impacts on an infant's cold symptoms between four nasal aspirator devices. These devices are normally used to relieve congestion in infants. when they are sick by softening and suctioning mucus from the nose. The main questions it aims to answer are: What is the caregiver's user experience of the NozeBot electric nasal aspirator compared to three commonly accessible nasal aspirator devices? Are there changes in the infant's sleeping, feeding, or breathing as reported by the caregiver when using the NozeBot compared to the three other nasal aspirator devices? Are there changes in their caregiver's habits when using the NozeBot compared to the three other nasal aspirator devices? Researchers will compare the self-reported measures of caregiver's user experience, reported changes to their infant's symptoms, and reported changes to their own sleeping and care habits between the NozeBot electric nasal aspirator and three comparator devices: the NoseFrida SnotSucker, the hydraSense Baby Nasal Aspirator Kit, and the Braun electric nasal aspirator. Participants will be assigned to receive one of the four devices at the start of their participation. They will be asked to use the assigned device at home according to the device instructions during two periods: (1) for 10 days while their infant is sick, and (2) for up to 3 months after. During these periods, participants will be asked to complete online surveys at predetermined intervals to report the user experience, any changes to their infant's sleeping, feeding or breathing, and any changes to their own sleeping habits and perceived stress levels. These intervals for survey completion are: (i) after 1-2 days of use while their infant is sick, (ii) after 4-5 days of use while their infant is sick, (iii) after 7-10 days of use while their infant is sick, and then (iv) biweekly for 3 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06816875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Children's Hospital of Eastern Ontario trials
Trials by the same sponsor.
- NCT06801366 — VIdeo Clips for Diagnostic Evaluation of Obstructive Sleep Apnea in Children · recruiting
- NCT06301477 — PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial · NA · active not recruiting
- NCT06232733 — HELP (HEalthy Lifestyles Project) for Youth With Mental Distress · NA · recruiting
- NCT06065215 — Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM) · recruiting
- NCT01344200 — CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06816875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Eastern Ontario
- Last refreshed: 2 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06816875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing